A 75-year-old client with chronic kidney disease and osteoarthritis is experiencing age-related physiological changes that affect medication metabolism. Which nursing intervention is the PRIORITY to prevent adverse drug reactions in this older adult?

Monitoring for drug toxicity and adjusting doses based on renal function is the priority to prevent adverse reactions due to age-related changes in metabolism. Other options are less critical (e.g., written instructions aid adherence but don't prevent toxicity) or potentially harmful (e.g., taking all medications together may increase side effects).

Understanding the Physiological Context
The priority concern for this 75-year-old client stems from the intersection of age-related physiological decline and the presence of chronic kidney disease (CKD). Aging inherently alters both pharmacokinetics (what the body does to a drug) and pharmacodynamics (what the drug does to the body). A critical pharmacokinetic change is the progressive decline in renal function, which directly reduces the clearance of many medications and their active metabolites ^[1]. When CKD is superimposed on this age-related decline, the capacity for drug excretion is severely compromised, creating a high-risk state for drug accumulation and toxicity if standard adult doses are administered ^[2].

Analyzing the Priority Intervention
Monitoring for signs of drug toxicity and adjusting dosing schedules based on renal function is the priority because it directly addresses the most dangerous physiological vulnerability in this client. Age-related biologic changes and alterations to pharmacokinetic variables are primary drivers of adverse drug reactions (ADRs) ^[1]. In the context of multimorbidity—here, CKD and osteoarthritis—the risk of ADRs is significantly amplified, particularly when polypharmacy is involved ^[2]. A "one-size-fits-all" medication approach is ineffective and unsafe in older adults precisely because of these altered pharmacokinetic parameters ^[3]. Therefore, the nursing action that mitigates the highest risk of harm is vigilant clinical assessment for signs of toxicity combined with advocating for dose adjustments based on the client's estimated glomerular filtration rate (eGFR). This proactive surveillance is a cornerstone of safe pharmacotherapy in geriatric patients with renal impairment.

Why Other Options Are Not the Priority
While the other interventions have value in geriatric care, they do not address the most immediate, life-threatening risk of drug toxicity from impaired elimination.
- Encouraging the client to take all medications with food to improve absorption is not a universal principle and can be dangerous. Food can alter the absorption of specific drugs, but the primary issue here is reduced drug elimination, not absorption. Furthermore, this action does not prevent toxicity from drugs that are already in the system.
- Providing written instructions in large print is an excellent strategy to address sensory limitations and improve medication adherence, which is a known drug therapy problem in geriatric patients ^[1][3]. However, non-adherence is a secondary concern compared to the immediate physiological danger of toxicity from a correctly taken but renally-cleared medication.
- Scheduling all medications at the same time for convenience is a strategy to simplify complex regimens and potentially improve adherence ^[1]. However, this approach can be outright dangerous if it leads to drug-drug interactions or peaks in drug concentration that an already compromised renal system cannot handle. The safety concern of toxicity outweighs the convenience factor.

The foundational principle is that in older adults with CKD, the body's ability to eliminate drugs is the most significantly altered and clinically impactful pharmacokinetic variable, making toxicity monitoring and dose adjustment the non-negotiable priority ^[1][2].